Skip to main content

Table 1 Comparisons in demographics, co-morbidities and primary outcomes across the study and between the non dialysis and dialysis groups

From: Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patients

 

Total (n = 23)

Dialysis Dependent (n = 9)

Non-Dialysis (n = 14)

Demographics

 Age (years),Median (IQR)

70 (66–78)

70 (53–71)

71.5 (66–80)

Sex

 Male, n (%)

15 (65.3)

7 (77.8)

8 (57.1)

 Female, n (%)

8 (34.7)

2 (22.2)

6 (42.9)

Clinical Frailty Score, Median

4.7

5.4

4.3

Disease Burden

 eGFR (ml/min), Median

  

64

 Procalcitonin (ng/ml),Median

1.58

3.89

0.43

 Hx chronic lung disease, n (%)

6 (26.1)

2 (22.2)

4 (28.6)

 Hx ischemic heart disease, n (%)

18 (78.2)

7 (77.8)

11 (78.6)

Primary outcomes

 30 day mortality, n (%)

12 (56.5)

1 (11.1)

11 (78.6)